Target intelligence / Profile preview

Immune cell populations (Paracrine and Cell-Cell Contact)

Molecular classification
Other
01

Overview

Immune cell populations interact within a complex network regulated by paracrine cytokines and direct cell-cell contact to coordinate host defense and maintain homeostasis (Nature Reviews Immunology, 2018). Paracrine signaling involves the secretion of soluble mediators like interleukins, interferons, and chemokines that influence the behavior of neighboring cells, while cell-cell contact relies on physical interactions between surface receptors and ligands, such as T-cell receptors (TCR) and major histocompatibility complex (MHC) molecules (Cell, 2020). In diseases such as cancer, this communication is often subverted to create an immunosuppressive microenvironment that allows for tumor evasion (Journal of Clinical Investigation, 2015). Conversely, in autoimmune disorders, dysregulated paracrine signaling can lead to chronic, self-destructive inflammation (Frontiers in Immunology, 2021). Therapeutic strategies targeting these interactions include monoclonal antibodies that block inhibitory checkpoints or neutralize pro-inflammatory cytokines, as well as cell-based therapies like CAR-T cells designed to engage specific cellular targets (Nature Reviews Drug Discovery, 2022). Understanding the spatial and temporal dynamics of these populations is critical for developing precision immunotherapies that can selectively modulate the immune response (Science, 2019).

Other names
Immune microenvironmentParacrine immune signalingCell-mediated immune communicationImmune synapse interactionsIntercellular immune signaling
02

Mechanism of action

Modulation of immune cell activity through the blockade or activation of paracrine signaling pathways (cytokines) and direct cell-surface receptor-ligand interactions (checkpoints) to restore or enhance immune function.

03

Biological functions

Immune responseSignal transductionCell-cell communicationInflammationCell proliferationApoptosis
04

Disease associations

CancerAutoimmune diseaseInfectionChronic inflammationGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Systemic immunosuppressionAutoimmunityInfusion reactions
06

Interacting drugs

9 more in the full profile.

07

Biomarkers

PD-L1 expressionTumor-infiltrating lymphocytes (TILs)Serum cytokine levels (IL-6, TNF-alpha)Interferon-gamma gene expression signatureCD8+ T cell density

Beyond the preview

Go deeper on Immune cell populations (Paracrine and Cell-Cell Contact).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cell populations (Paracrine and Cell-Cell Contact).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call